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The Impact of MRSA on Vascular Surgery
A. Nasim∗, M. M. Thompson, A. R. Naylor, P. R. F. Bell and N. J. M. London
Department of Vascular and Endovascular Surgery, Leicester Royal Infirmary NHS Trust, Leicester LE1 5WW, U.K.
Objectives: to investigate the prevalence of MRSA infection in patients treated in a major vascular unit and examine
its consequences.
Design and Methods: a retrospective case-note review was performed.
Results: during the period 1993 to 2000, a total of 172 patients (4.4% of total) were positive for MRSA. Of these 97
were colonised and 75 were infected by MRSA. The proportion of wound or graft infections caused by MRSA has
increased (4% in 1994 to 63% in 2000). Three patients developed native artery infection (one following aortic stent
insertion and 2 following embolectomy). All patients with aortic graft infection died. All patients with infected prosthetic
infrainguinal bypass ended up with an amputation.
Conclusion: the prevalence of MRSA infection is increasing. Infection of aortic grafts appears to be uniformly fatal and
lower limb graft infection is associated with high limb loss.
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Introduction were identified from the Leicester Royal Infirmary
(LRI) Vascular Studies Unit audit (prospective data
collection on admissions), and microbiology recordsStaphylococcus aureus is a highly virulent and ubi-
for the period January 1993 to December 2000. Thequitous pathogen. It is the commonest cause of surgical
case notes of all patients were retrieved and reviewedwound infections.1 After the initial success of penicillin
to obtain data on presentation, diagnosis, treatment,in treating S. aureus, resistance began to emerge and
complications and survival. Patients were notnow up to 80 percent of isolates are penicillin resistant.2
routinely screened for MRSA prior to admission exceptThe introduction of -lactamase resistant semis-
for those transferred from other hospitals. However,ynthetic penicillins in the 1960s provided temporary
there was a routine policy of screening all patientsrespite until the emergence of methicillin-resistant S.
admitted to the intensive care or the high dependencyaureus (MRSA).3,4 In recent years MRSA has become
unit. All patients underwent surgery in LRI. Antibioticendemic in hospitals in Europe and U.S.A. The in-
prophylaxis comprised of 3 doses of intravenous ce-creasing prevalence of MRSA is a major threat in
furoxime (750 mg) and metronidazole (500 mg) in allarterial surgery and poses a considerable therapeutic
patients undergoing arterial surgery. The first dosechallenge. This paper reports the prevalence of MRSA
was administered at induction of anaesthesia and sub-in a major teaching hospital vascular unit and the
sequent 2 doses were given at 8 h intervals post-consequences of infection with this organism are dis-
operatively.cussed.
For the purposes of this study, colonisation was
defined as patients who were swab positive for MRSA
with no clinical evidence of infection. Patients were
Patients and Methods considered to be infected if there was clinical evidence
of infection at the cultured site. Graft infection was
A retrospective study was undertaken to assess the defined as positive MRSA culture from fluid or pus
prevalence of MRSA and the consequences of MRSA in direct contact with the graft. Data was analysed by
wound and graft infections. Patients positive for MRSA using the total number of arterial procedures per-
formed as the denominator. However, this figure ex-
cluded those patients undergoing angioplasties or
∗ Please address all correspondence to: A. Nasim, Consultant Vas-
varicose vein surgery, but included patients with ven-cular Surgeon, Withington Hospital, Nell Lane, West Didsbury,
Manchester M20 8LE. ous ulcers undergoing surgery.
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MRSA colonisation and infection during the study
period for aortic procedures, carotid endarterectomy
and infrainguinal reconstructions are shown in Table
1.
Table 2 gives a summary of the 75 patients with
MRSA infection. Three patients presented with Dacron
patch infection following carotid endarterectomy. In
one patient, the infected Dacron patch was removed,
and the common carotid, internal carotid and external
carotid arteries were excised and ligated under trans-
cranial Doppler monitoring. The second patient pre-
sented 2 years post carotid endarterectomy with a
discharging sinus overlying the carotid patch. The
internal carotid was found to be occluded on Duplex
scanning. The Dacron patch was removed, and the
external and common carotid arteries were ligated.
Both of these patients made an uneventful recovery.
The third patient underwent excision of the infectedFig. 1. Proportion (%) of MRSA positive patients by year from
carotid artery and a vein graft was inserted. This1994–2000.
patient survived but developed a hemiparesis. In
elective aortic aneurysm surgery 3 patients had been
treated by endovascular technique. One of these de-
veloped a false aneurysm at the site of insertion of the
endovascular device, this was repaired and the patient
survived. The second patient developed a crossover
graft infection after endovascular aortic aneurysm re-
pair with an aorto-uni-iliac device and died. The third
patient developed a groin wound infection which
resolved with a 6 week course of intravenous van-
comycin therapy (1 g twice daily with monitoring of
levels to guide dosage and avoid toxicity). One patient
developed intra-abdominal sepsis after an aorto-bi-
femoral graft and died. All patients with aortic graftFig. 2. Number of patients with colonisation or clinical infection by
infection following repair of a ruptured aneurysm andMRSA.
reconstruction for occlusive aortic disease died.
Twenty-five of the patients undergoing lower limbResults
procedures had wound infections and 6 of these died
from unrelated causes. Two patients developed a prim-The first MRSA positive patient in the Leicester Royal
ary arterial infection after a femoral embolectomy.Infirmary vascular unit was identified in 1993. During
Both presented about 2 weeks after the primary pro-the 8 year period from 1993 to 2000, a total of 172
cedure with arterial rupture and haemorrhage. In thepatients were positive for MRSA. This represented
first patient this was repaired with a vein patch. How-4.4% of the patients passing through the vascular unit
ever, 5 days later the vein patch ruptured and anduring the study period. Of the 172 patients, 97 were
obturator bypass (with PTFE) was performed. Thecolonised and 75 were infected by MRSA. The number
limb was salvaged and the patient survived. The sec-of MRSA positive patients has increased yearly (Fig.
ond patient underwent ligation of the femoral artery1), from 6 (1%) patients in 1994 to 28 (6.8%) patients
and an above knee amputation. The amputation stumpin 2000. Each year, roughly 50% of the MRSA positive
also became infected with MRSA. He declined furtherpatients have developed a clinical infection (Fig. 2).
surgery and died of MRSA sepsis. Eight patients de-The overall wound and graft infection rate has
veloped graft infections. One of these was a Dacronremained similar over the years (5% in 1994 versus
iliofemoral crossover, and the patient required an4.6% in 2000). However, the proportion of wound or
above knee amputation and survived. Two patientsgraft infections caused by MRSA has increased from
1/28 (4%) in 1994 to 12/19 (63%) in 2000. The risks of had infected PTFE femoropopliteal bypass grafts. The
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Table 1. Incidence (%) of MRSA carriage, infection and graft infection during the period
1993–2000.
MRSA MRSA MRSA graft
carriage infection infection
Carotid endarterectomy 0.5 0.25 0.25
Aortic procedure 5 3 0.7
Lower limb arterial procedure 7 3 0.7
Table 2. Summary of the 75 MRSA infections.
Type of procedure No. Site of MRSA sepsis Outcome Median (range) hospital
stay in days
Brachial embolectomy 1 Wound Resolved
Carotid endarterectomy 3 Dacron patch 1 hemiparesis 22 (15–38)
Elective AAA repair 21 Pneumonia (11)∗ 4 died∗ 24 (9–87)
Septicaemia (3)
Wound (4)
Groin false aneurysm (1)
X-over graft (1)∗
Intra-abdominal sepsis (1)∗
Ruptured AAA repair 11 Pneumonia (5) 3 died∗∗ 33 (13–80)
Wound (2)
Graft (3)∗∗
Septicaemia (1)
Aortic occlusive disease 4 Wound (2) 2 died∗∗∗ 26 (12–260)
Graft (2)∗∗∗
Lower limb surgery 35 Wound (25) 9 died 30 (13–90)
Graft (8) 6 amputations
Primary arterial infection (2)
grafts were removed and an above knee amputation methicillin-susceptible S. aureus infections.9 The in-
was performed. Five vein grafts became infected, 1 crease in MRSA cases in our unit has occurred despite
was salvaged successfully with wound debridement, isolation of MRSA cases and the implementation of
sartorius muscle flap and vancomycin therapy and 3 appropriate guidelines.10
required an amputation and 1 patient died. One patient The greatest impact of hospital MRSA infections is
did not undergo amputation and died of MRSA sepsis. likely to be in areas such as vascular surgery which
utilise prosthetic graft materials and where the patient
population is frail and debilitated.11 Infection of aortic
grafts appears to be uniformly fatal. Infection of lowerDiscussion
limb bypass grafts is either fatal from overwhelming
sepsis or leads to limb loss. Limb salvage may beThe prevalence of MRSA appears to be steadily in-
possible in some patients by total graft excision andcreasing which is reflected in our figures and those
revascularisation of the limb with autogenous veinreported from other vascular units.5,6 In Trent in 1998,
graft routed through clean tissue planes.6 The most20% of S. aureus causing bacteraemia were methicillin
worrying finding in our study was the ability of MRSAresistant whereas the overall figure for England and
to destroy native artery (3 patients with primary clos-Wales,7 was 32%. In the United States, MRSA has also
ure of a femoral arteriotomy) and the susceptibility ofincreased at an alarming rate since the 1980s. In 1984,
vein grafts to MRSA infection. Native artery MRSAthe overall proportion of S. aureus resistant to me-
infection has not been reported previously. Whetherthicillin was approximately 5%, but this increased
this represents a genuinely increased pathogenicity ofsharply to 29% by 1991.8 This has considerable im-
MRSA compared to methicillin-sensitive S. aureus orplications in terms of hospital costs. Our results suggest
simply reflects the relatively poor activity of van-a prolonged hospital stay in some patients although
comycin against MRSA is uncertain.we have not used a control group for comparison.
Until recently, vancomycin has been the onlyOne study from the U.S.A. has shown that patients
uniformly effective treatment for staphylococcalwith serious MRSA infection stayed in hospital an
infections. However, intermediate resistance to gly-average of 12 days longer and had an average hospital
cost of £3200 greater than comparable patients with copeptides has now been reported from Japan and the
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